Letybo Side Effects
Generic name: letibotulinumtoxinA
Note: This document provides detailed information about Letybo.
Applies to letibotulinumtoxinA: intramuscular powder for injection Side Effects associated with letibotulinumtoxinA. Some dosage forms listed on this page may not apply specifically to the brand name Letybo.
Applies to letibotulinumtoxinA: intramuscular powder for injection.
General adverse events
The most common adverse reaction occurring in more than 2% of patients was headache. Adverse reactions may occur within the first few days following injection and may have a transient duration of up to several months or longer.[Ref]
Dermatologic
Gastrointestinal
- Rare (0.01% to 0.1%): Constipation, nausea, oral herpes
- Frequency not reported: Dysphagia[Ref]
Immunologic
- Uncommon (0.1% to 1%): Anti-drug antibodies
Local
- Common (1% to 10%): Injection site reaction
- Uncommon (0.1% to 1%): Injection site: Pain, pressure, bruising, swelling, pruritus, mass
- Rare (0.01% to 0.1%): Folliculitis, periorbital hematoma, contusion
- Frequency not reported: Injection site: Nodule, inflammation, tenderness, erythema, itching, bleeding[Ref]
Metabolic
- Rare (0.01% to 0.1%): Increased serum potassium[Ref]
Musculoskeletal
- Frequency not reported: Local muscle weakness (expected due to pharmacological action of botulinum toxin in muscle tissue)[Ref]
Ocular
- Uncommon (0.1% to 1%): Eyelid ptosis, blepharospasm, periorbital edema
- Rare (0.01% to 0.1%): Conjunctival hemorrhage, dry eye, eye pain[Ref]
Respiratory
- Common (1% to 10%): Nasopharyngitis, bronchitis
- Rare (0.01% to 0.1%): Pharyngeal hypoesthesia, streptococcal pharyngitis, pneumonia, sinusitis[Ref]
Nervous system
- Common (1% to 10%): Headache
- Uncommon (0.1% to 1%): Head discomfort
- Rare (0.01% to 0.1%): Migraine, dizziness, paresthesia, visual field defect
- Frequency not reported: Procedural headache[Ref]
References
1. (2023) "Product Information. Letybo (letibotulinumtoxinA)." Croma Aesthetics Canada, Ltd
2. (2022) "Product Information. Letybo (letibotulinumtoxinA)." CROMA Australia Pty Ltd, 1
3. (2024) "Product Information. Letybo (letibotulinumtoxinA)." Hugel Aesthetics
Frequently asked questions
More about Letybo (letibotulinumtoxinA)
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: skeletal muscle relaxants
Patient resources
Professional resources
Related treatment guides
Further information
Letybo side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.